Democritus University of Thrace (DUTH)
Η αλληλεπίδραση των ενδογενών ρετροϊών και της μεταγωγικής οδού των ιντερφερονών με την υπομεθυλιωτική θεραπεία στα Μυελοδυσπλαστικά Σύνδρομα
Abstract
dc:descriptionMyelodysplastic syndromes (MDS) and acute myelogenous leukemia (AML) are characterized by abnormal patterns of DNA methylation, which contribute to the pathophysiology of the disease, resulting in abnormal epigenetic suppression and differentiation of hematopoietic stem cells (HSCs). Hypomethylating agents (HMAs), which reverse this epigenetic suppression, such as 5-azacitidine (AZA) and 5-aza-2'-deoxycytidine (DAC), remain the main treatment of choice for patients with high-risk MDS and AML. Nevertheless, the exact mechanism of action of HMAs remains unclear, while prognostic factors of response to HMAs are absent. Recent data on cancer cell lines suggest that reactivation of endogenous retroviral elements and subsequent induction of an endogenous cellular antiviral response may be the background of the anti-cancer activity of HMA.Using RNA sequencing (RNA-seq), a comparison of endogenous retroviral transcript levels in HSC isolated from the bone marrow of patients with MDS and chronic myelomonocytic leukemia II (CMML-II), before and after treatment with AZA, and HSCs derived from bone marrow from healthy donors and patients with AM was performed.In agreement with previous literature reports, it was found that AZA treatment increased the transcription of endogenous retroviral elements. However, this increase was not correlated with the clinical response to AZA treatment, as it was observed in both responders and non-responders patients. This observation was also confirmed by performing de novo transcript assembly, revealing that AZA-responsive endogenous retroviruses are not a determinant of the outcome of the HMA treatment. There was also observed a lack of induction of an antiviral response of interferons associated with the AZA response. In contrast, it has been found that the therapeutic expression and alternative splicing process of specific, developmentally regulated genes may be prognostic factors for the response of patients with MDS and CMML-II to AZA therapy. In conclusion, this doctoral thesis identifies the developmentally regulated transcriptional signatures of protein-coding and non-coding genes, rather than endogenous retroviral elements, as correlates of a favourable response of MDS and CMML-II patients to AZA treatment and offers novel candidates for further evaluation.
Degree
thesis:*- Grantor dc:publisher
- Democritus University of Thrace (DUTH)
- Year dc:date
- 2021
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Kordella, Chrysoula
- Κορδελλά, Χρυσούλα
Subjects
dc:subject × 18- Μυελοδυσπλαστικά σύνδρομα (MDS)
- Υπομεθυλιωτικοί παράγοντες 5azacytidine 5AZADC
- Ενδογενείς ρετροϊοί
- Ιντερφερόνες
- Myelodysplastic syndromes
- Hypomethylating agents
- Ηuman endogenous retroviruses
- Interferons
- Βασική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Ανοσολογία
- Κλινική Ιατρική
- Αιματολογία
- Basic Medicine
- Medical and Health Sciences
- Immunology
- Clinical Medicine
- Hematology
Rights
dc:rights- Statement dc:rights
-
- BY_4_0
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/49263